Margaret Stalker

University of Colorado Anschutz Medical Campus — United States

Medicine · Health Sciences

17h-index1.0kcitations58works2.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Lung Cancer Treatments and Mutations(10), Glutathione Transferases and Polymorphisms(6), Lung Cancer Diagnosis and Treatment(4), Multiple Myeloma Research and Treatments(4), Gastric Cancer Management and Outcomes(4)

Publications58 total

Dysregulated Fatty Acid Metabolism in Preeclampsia Among Highland Andeans: Insights Into Adaptive and Maladaptive Placental Metabolic Phenotypes
The FASEB Journal·2025Open Access
Incidence and Outcomes of Brain Metastasis in Pleural Mesothelioma in the Era of Immunotherapy
JTO Clinical and Research Reports·2025Open Access
“Off-Label” Use of Checkpoint Inhibitors in Patients With Negative or Unknown PD-L1 Status in Advanced Head and Neck Cancer
Journal of the National Comprehensive Cancer Network·2025· 1 cited
Brief Report: Osimertinib Plus Capmatinib for Patients With MET-Altered EGFR-Mutant NSCLC Following Progression on Front Line Therapy
Clinical Lung Cancer·2024· 3 cited
The efficacy of continuing osimertinib with platinum pemetrexed chemotherapy upon progression in patients with metastatic non-small cell lung cancer harboring sensitizing EGFR mutations
Lung Cancer·2024· 9 citedOpen Access
Changing Treatment and Metastatic Disease Patterns in Patients with EGFR Mutated Non-Small Cell Lung Cancer: An ATOMIC Registry Analysis
UNC Libraries·2024Open Access
Safety and Efficacy of Teclistamab in Patients With Relapsed or Refractory <scp>AL</scp> Amyloidosis
European Journal Of Haematology·2024· 9 citedOpen Access
Changing Treatment and Metastatic Disease Patterns in Patients with EGFR Mutated NSCLC: An Academic Thoracic Medical Investigator’s Consortium Registry Analysis
JTO Clinical and Research Reports·2024· 1 citedOpen Access
Outcomes Following Treatment for Progression in Patients Treated With Durvalumab Consolidation in LA-NSCLC
Clinical Lung Cancer·2024· 3 cited
P1.08D.02 Survival after Salvage Treatment Following Durvalumab Consolidation in Locally Advanced Non-Small Cell Lung Cancer (LA-NSCLC)
Journal of Thoracic Oncology·2024Open Access
Brain metastases in patients with pleural mesothelioma receiving dual checkpoint blockade compared to single-agent checkpoint blockade or chemotherapy.
Journal of Clinical Oncology·2024
Off-label use of checkpoint inhibitor (CPI) monotherapy in PD-L1–negative or unknown recurrent/metastatic head and neck cancer (R/M HNSCC).
Journal of Clinical Oncology·2024Open Access
The Efficacy and Safety of Treating Acquired MET Resistance Through Combinations of Parent and MET Tyrosine Kinase Inhibitors in Patients With Metastatic Oncogene-Driven NSCLC
JTO Clinical and Research Reports·2024· 8 citedOpen Access
Colonic gastrointestinal stromal tumor (GIST) presenting with colocolonic intussusception: A rare case report.
PubMed·2024Open Access
Outcomes Following Treatment for Progression in Patients Treated with Durvalumab Consolidation in La-Nsclc
SSRN Electronic Journal·2024Open Access
Safety and Efficacy of Teclistamab in Patients with Relapsed or Refractory AL Amyloidosis: A Retrospective Case Series
Blood·2023· 2 cited
Unilateral primary carcinoma of the kidney with central nervous system invasion and vertebral lysis in a cat
Journal of Feline Medicine and Surgery Open Reports·2022· 1 citedOpen Access
Clinical Management of Triple-Class Refractory Multiple Myeloma: A Review of Current Strategies and Emerging Therapies
Current Oncology·2022· 25 citedOpen Access
Vascular Disorders of Pregnancy Increase Susceptibility to Neonatal Pulmonary Hypertension in High-Altitude Populations.
Apollo (University of Cambridge)·2022· 20 citedOpen Access
Sustained Response to Selinexor-Based Therapy for Triple-Class Refractory Multiple Myeloma with Early Relapse After Allogeneic Stem Cell Transplantation
Clinical Lymphoma Myeloma & Leukemia·2021· 1 cited
page 1 of 3Next →

Frequent Co-authors

Melina E. Marmarelis(8), M. Anthony Hayes(7), Lova Sun(6), Charu Aggarwal(5), Grant Kirby(4), T. E. Kocal(4), Tejas Patil(4), Dara L. Aisner(4), Roger B. Cohen(4), Corey J. Langer(4), Ðurđa Slavić(3), Bette Anne Quinn(3), Amanda Cass(3), Wade T. Iams(3), D. Ross Camidge(3), Wei‐Ting Hwang(3), John M. Cullen(2), Julius M. Liptak(2), Murray Hazlett(2), J Delay(2)